| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb Co (BMY) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. BMY is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 204.7K | $11.50M | - | |
| CFO | 167.4K | $9.40M | - | |
| Dir | 66.1K | $3.71M | - | |
| Dir | 63.2K | $3.55M | - | |
| Dir | 38.9K | $2.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | Powell Ann64 | EVP, Chief Human Resources | Sell | 25,000 | $70.75 | $1,768,750.00 | -33.1% | +10.6% | -14.9% | |
| Sep 13, 2022 | Elkins David V | EVP, Chief Financial Officer | Sale+OE | 133,951 | $71.30 | $9,551,166.79 | -37.8% | +11.9% | -15.4% | |
| Jun 13, 2022 | Caforio Giovanni59 | Board Chair And CEO | Sell | 30,000 | $74.04 | $2,221,200.00 | -5.2% | -1.0% | -10.7% | |
| Jun 6, 2022 | Leung Sandra | EVP, General Counsel | Sell | 65,000 | $74.89 | $4,867,850.00 | -17.4% | -8.1% | -11.7% | |
| Mar 21, 2022 | Caforio Giovanni59 | Board Chair And CEO | Sell | 25,000 | $71.52 | $1,788,000.00 | -4.1% | +8.4% | -2.9% | |
| Mar 16, 2022 | Vessey Rupert53 | EVP, Research &Early Dev. | Sale+OE | 74,559 | $69.25 | $5,162,972.81 | -43.5% | +5.4% | -1.5% | |
| Mar 14, 2022 | Santiago Karen Murphy | SVP &Controller | Sell | 6,577 | $69.20 | $455,095.51 | -28.3% | +7.1% | -1.9% | |
| Mar 14, 2022 | Boerner Christopher S.60 | EVP, Chief Commercial Officer | Sell | 29,532 | $69.20 | $2,043,525.80 | -41.3% | +7.1% | -1.9% | |
| Feb 24, 2022 | Caforio Giovanni59 | Board Chair And CEO | Sell | 30,000 | $67.00 | $2,010,000.00 | -6.2% | +16.0% | +6.9% | |
| Dec 16, 2021 | Vessey Rupert53 | EVP, Research &Early Dev. | Sell | 19,298 | $61.99 | $1,196,252.03 | -20.0% | +13.0% | +21.9% |